604 related articles for article (PubMed ID: 22849744)
1. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
2. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Senetta R; Paglierani M; Massi D
Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
[TBL] [Abstract][Full Text] [Related]
4. A proposal for improving multicolor FISH sensitivity in the diagnosis of malignant melanoma using new combined criteria.
Kerl K; Palmedo G; Wiesner T; Mentzel T; Rütten A; Schärer L; Paredes B; Hantschke M; Kutzner H
Am J Dermatopathol; 2012 Aug; 34(6):580-5. PubMed ID: 22668575
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
[TBL] [Abstract][Full Text] [Related]
7. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
[TBL] [Abstract][Full Text] [Related]
8. What's new in prognostication of melanoma in the dermatopathology laboratory?
Bangash HK; Romegialli A; Dadras SS
Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
Lampert A; Thomine E; Lauret P; Hemet J
Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of COX-2 protein expression in melanocytic nevi in children].
Kubus M; Andrzejewska E; Nejc D; Kobos J; Taran K
Pol Merkur Lekarski; 2013 Aug; 35(206):82-4. PubMed ID: 24052986
[TBL] [Abstract][Full Text] [Related]
11. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
Bauer J; Bastian BC
Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
[TBL] [Abstract][Full Text] [Related]
13. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
[TBL] [Abstract][Full Text] [Related]
14. Significant melanocytic lesions in infancy, childhood, and adolescence.
Hoss DM; Grant-Kels JM
Dermatol Clin; 1986 Jan; 4(1):29-44. PubMed ID: 3521978
[TBL] [Abstract][Full Text] [Related]
15. Polypoid Spitz nevus: two cases evaluated with genetic technique, prolonged follow up, and sentinel lymph node biopsy.
Pennacchia I; Gasbarra R; Manente L; Pisa R; Garcovich S; Ricci R; Ruggeri C; Massi G
J Cutan Pathol; 2011 Sep; 38(9):747-52. PubMed ID: 21645037
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
Gerami P; Alsobrook JP; Palmer TJ; Robin HS
J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
[TBL] [Abstract][Full Text] [Related]
18. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
19. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features.
Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P
J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759
[TBL] [Abstract][Full Text] [Related]
20. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]